Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Adlai Nortye Announces First Patient Dosed in Phase I Clinical Trial of the orally available, small-molecule PD-L1 inhibitor AN4005 for Advanced Tumors 2022-01-06 01:00
Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference 2022-01-05 20:45
PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech 2022-01-05 09:00
Harbour BioMed Announces Dosing of First Patient of Two Phase I Trials for Next-Generation Anti-CTLA-4 Antibody HBM4003 2022-01-04 17:28
AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CONCURRENT CHEMORADIOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER 2022-01-04 10:00
Asieris Announces the World's First Patient Dose Administered in Combination of Asieris'APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients 2022-01-04 08:06
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD 2022-01-03 18:00
I-Mab Announces Upcoming Participation at January Conferences 2021-12-31 21:00
China Medical System (867.HK)'s Latest MSCI ESG Rating Unchanged at AA, Leading the Industry Globally 2021-12-30 20:00
SyMap Medical Ltd. Announces its Strategic Collaboration with Pythagoras Medical 2021-12-29 20:30
EOFlow and Zihipp Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & NASH 2021-12-28 22:00
Akeso's IL-17A MONOCLONAL ANTIBODY (GUMOKIMAB) COMPLETION OF PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS 2021-12-28 12:30
Regor Therapeutics Announces U.S. FDA Authorization to Conduct Regor's First-in-Human Clinical Trial with the Next Generation Targeted Inhibitor RGT-419B for Oncology 2021-12-28 09:00
I-Mab Announces IND Approval from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors 2021-12-27 21:00
Kintor Pharma Provides Update on One of its Three Multi-Regional Phase 3 Trials of Proxalutamide for COVID-19 2021-12-27 20:19
Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase 2021-12-24 16:30
Yiling Pharmaceutical's Patent Depression-resolving Drug Approved for Marketing in China 2021-12-23 11:59
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China 2021-12-23 07:44
AMO Pharma Announces Expansion of Pivotal REACH-CDM Study in Congenital Myotonic Dystrophy 2021-12-22 21:00
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines 2021-12-22 19:00
1 88 89 90 91 92 165